Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10729 | 2021 |
Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: implications for metabolic regulation and bioactivity UB Pajvani, X Du, TP Combs, AH Berg, MW Rajala, T Schulthess, J Engel, ... Journal of Biological Chemistry 278 (11), 9073-9085, 2003 | 1515 | 2003 |
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity UB Pajvani, M Hawkins, TP Combs, MW Rajala, T Doebber, JP Berger, ... Journal of Biological Chemistry 279 (13), 12152-12162, 2004 | 1495 | 2004 |
Adiponectin acts in the brain to decrease body weight Y Qi, N Takahashi, SM Hileman, HR Patel, AH Berg, UB Pajvani, ... Nature medicine 10 (5), 524-529, 2004 | 1073 | 2004 |
Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor γ agonists AR Nawrocki, MW Rajala, E Tomas, UB Pajvani, AK Saha, ME Trumbauer, ... Journal of Biological Chemistry 281 (5), 2654-2660, 2006 | 821 | 2006 |
A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity TP Combs, UB Pajvani, AH Berg, Y Lin, LA Jelicks, M Laplante, ... Endocrinology 145 (1), 367-383, 2004 | 715 | 2004 |
Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting MW Rajala, Y Qi, HR Patel, N Takahashi, R Banerjee, UB Pajvani, ... Diabetes 53 (7), 1671-1679, 2004 | 474 | 2004 |
Mechanisms of fibrosis development in nonalcoholic steatohepatitis RF Schwabe, I Tabas, UB Pajvani Gastroenterology 158 (7), 1913-1928, 2020 | 451 | 2020 |
Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy UB Pajvani, ME Trujillo, TP Combs, P Iyengar, L Jelicks, KA Roth, ... Nature medicine 11 (7), 797-803, 2005 | 370 | 2005 |
Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes J Tonelli, W Li, P Kishore, UB Pajvani, E Kwon, C Weaver, PE Scherer, ... Diabetes 53 (6), 1621-1629, 2004 | 330 | 2004 |
Adiponectin: systemic contributor to insulin sensitivity UB Pajvani, PE Scherer Current diabetes reports 3 (3), 207-213, 2003 | 316 | 2003 |
Selective downregulation of the high–molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects R Basu, UB Pajvani, RA Rizza, PE Scherer Diabetes 56 (8), 2174-2177, 2007 | 248 | 2007 |
Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity L Ozcan, CCL Wong, G Li, T Xu, U Pajvani, SKR Park, A Wronska, ... Cell metabolism 15 (5), 739-751, 2012 | 230 | 2012 |
Adiponectin: a relevant player in PPARγ-agonist-mediated improvements in hepatic insulin sensitivity? M Bouskila, UB Pajvani, PE Scherer International journal of obesity 29 (1), S17-S23, 2005 | 214 | 2005 |
Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner UB Pajvani, CJ Shawber, VT Samuel, AL Birkenfeld, GI Shulman, ... Nature medicine 17 (8), 961-967, 2011 | 206 | 2011 |
Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes? L Valenti, E Bugianesi, U Pajvani, G Targher Liver International 36 (11), 1563-1579, 2016 | 191 | 2016 |
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis C Zhu, KJ Kim, X Wang, A Bartolome, M Salomao, P Dongiovanni, ... Science translational medicine 10 (468), eaat0344, 2018 | 182 | 2018 |
Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability UB Pajvani, L Qiang, T Kangsamaksin, J Kitajewski, HN Ginsberg, ... Nature medicine 19 (8), 1054-1060, 2013 | 170 | 2013 |
Molecular pathophysiology of metabolic effects of antipsychotic medications JS Ballon, U Pajvani, Z Freyberg, RL Leibel, JA Lieberman Trends in Endocrinology & Metabolism 25 (11), 593-600, 2014 | 143 | 2014 |
Cholesterol stabilizes TAZ in hepatocytes to promote experimental non-alcoholic steatohepatitis X Wang, B Cai, X Yang, OO Sonubi, ZE Zheng, R Ramakrishnan, H Shi, ... Cell metabolism 31 (5), 969-986. e7, 2020 | 140 | 2020 |